# Subcutaneous pertuzumab–trastuzumab: Efficiency, safety, and the biosimilar horizon

**Authors:** Asim Armagan Aydin, Erkan Kayikcioglu

PMC · DOI: 10.1016/j.breast.2025.104651 · The Breast : Official Journal of the European Society of Mastology · 2025-11-19

## Full-text entities

- **Chemicals:** pertuzumab (MESH:C485206), trastuzumab (MESH:D000068878)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13031144/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC13031144/full.md

---
Source: https://tomesphere.com/paper/PMC13031144